ImmunoGen Announces Departure of Anna Berkenblit, Chief Medical Officer
ImmunoGen, Inc. , a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, today announced that Anna Berkenblit, MD, Senior Vice President and Chief Medical Officer,...
Source: marketscreener.com